| Effects of B cell depletion on early Mycobacterium tuberculosis infection in cynomolgus macaques J Phuah, EA Wong, HP Gideon, P Maiello, MT Coleman, MR Hendricks, ... Infection and immunity 84 (5), 1301-1311, 2016 | 135 | 2016 |
| Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis RM DiFazio, JT Mattila, EC Klein, LR Cirrincione, M Howard, EA Wong, ... Fibrogenesis & tissue repair 9, 1-11, 2016 | 71 | 2016 |
| Sex and gender differences in clinical pharmacology: implications for transgender medicine LR Cirrincione, KJ Huang Clinical Pharmacology & Therapeutics 110 (4), 897-908, 2021 | 44 | 2021 |
| Drug interactions with gender-affirming hormone therapy: focus on antiretrovirals and direct acting antivirals LR Cirrincione, T Senneker, KK Scarsi, A Tseng Expert Opinion on Drug Metabolism & Toxicology 16 (7), 565-581, 2020 | 25 | 2020 |
| Limited evidence for use of a black race modifier in eGFR calculations: a systematic review MA Marzinke, DN Greene, PM Bossuyt, AB Chambliss, LR Cirrincione, ... Clinical chemistry 68 (4), 521-533, 2022 | 22 | 2022 |
| Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapy LR Cirrincione, AT Podany, JP Havens, SH Bares, SR Dyavar, Y Gwon, ... Journal of Antimicrobial Chemotherapy 75 (5), 1242-1249, 2020 | 21 | 2020 |
| Sublingual estradiol is associated with higher estrone concentrations than transdermal or injectable preparations in transgender women and gender nonbinary adults LR Cirrincione, G Winston McPherson, J Rongitsch, K Sadilkova, ... LGBT health 8 (2), 125-132, 2021 | 19 | 2021 |
| A retrospective analysis of creatinine-based kidney function with and without sex assigned at birth among transgender adults SK Fadich, A Kalayjian, DN Greene, LR Cirrincione Annals of Pharmacotherapy 56 (7), 791-799, 2022 | 17 | 2022 |
| Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma LR Cirrincione, SD Penchala, KK Scarsi, AT Podany, LC Winchester, ... Journal of Chromatography B 1084, 106-112, 2018 | 17 | 2018 |
| A holistic framework for the evaluation of kidney function in a gender-diverse landscape KT Miranda, DN Greene, D Collister, MD Krasowski, SB Ahmed, ... American journal of kidney diseases 84 (2), 232-240, 2024 | 13 | 2024 |
| Inclusion of transgender and gender diverse people in phase III trials: examples from HIV pharmacologic prevention studies LR Cirrincione, VLB Grieve, J Holloway, MA Marzinke Clinical Pharmacology & Therapeutics 113 (3), 557-564, 2023 | 13 | 2023 |
| Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine A Le, KJ Huang, LR Cirrincione Trends in Pharmacological Sciences 43 (7), 582-592, 2022 | 11 | 2022 |
| Oral estrogen leads to falsely low concentrations of estradiol in a common immunoassay LR Cirrincione, BO Crews, JA Dickerson, MD Krasowski, J Rongitsch, ... Endocrine Connections 11 (2), 2022 | 11 | 2022 |
| Drug interactions in infectious diseases: antimicrobial drug interactions MP Pai, JJ Kiser, PO Gubbins, KA Rodvold Springer, 2018 | 7 | 2018 |
| Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study LR Cirrincione, S Nakalema, CA Chappell, P Byakika-Kibwika, ... Contraception 122, 109975, 2023 | 6 | 2023 |
| Gender-affirming hormone therapy and bone health: do different regimens influence outcomes in transgender adults? A narrative review and call for future studies LR Cirrincione, RR Narla The Journal of Applied Laboratory Medicine 6 (1), 219-235, 2021 | 6 | 2021 |
| Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy A Kalayjian, K Laszlo, M Fassler, Z Schonrock, KE Delarose, AM Ly, ... Journal of the American Pharmacists Association 64 (1), 283-289. e2, 2024 | 5 | 2024 |
| Transgender people in clinical trials of drugs and biologics: An analysis of ClinicalTrials. gov from 2007 to 2023 Z Schonrock, S Brackeen, KE Delarose, TQD Tran, LR Cirrincione British Journal of Clinical Pharmacology 90 (10), 2332-2342, 2024 | 4 | 2024 |
| Drug interactions in HIV: Nucleoside, nucleotide, and nonnucleoside reverse transcriptase inhibitors and entry inhibitors LR Cirrincione, KK Scarsi Drug interactions in infectious diseases: Antimicrobial drug interactions …, 2018 | 4 | 2018 |
| Clinical pharmacology in adolescent transgender medicine LR Cirrincione, KJ Huang, GM Sequeira British Journal of Clinical Pharmacology 90 (10), 2387-2397, 2024 | 1 | 2024 |